Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.
about
Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report.Hepatitis B serological markers and plasma DNA concentrations.Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: occult or overt--that is the question.Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies.Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus.Chronic hepatitis B and C co-infection increased all-cause mortality in HAART-naive HIV patients in Northern ThailandHepatitis B virus infection and transfusion medicine: science and the occult.The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.Hepatitis B Core Antibody Negativity in a Chronic Hepatitis B Infected Patient: Report of an Unusual Serological Pattern.Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor.Reactivation of occult hepatitis B virus infection following cytotoxic lymphoma therapy in an anti-HBc negative patient.Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.The perils of relying on anti-hepatitis B total core antibody in screening individuals infected with HIV.Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity SettingHepatitis B Virus Seroprevalence and Serology Patterns in a Cohort of HIV Positive Individuals from Harare, Zimbabwe
P2860
Q33568712-AFD70B32-9426-4CF9-88A2-860B48DBAC4AQ33631046-9F70E544-F3CB-4BB7-8795-F65CA52D39E6Q34437586-4AE8BFE9-A87A-4BF8-B95A-9CCF38A996ABQ36752181-9AA79AF3-F284-4114-8A28-5F51140CD759Q36980710-FED773A7-2C98-488A-A51B-2F5AC216ABB2Q37132597-F3FD6BBD-D278-4388-B92C-DCE7286FD759Q37153782-75B71258-1F5C-4F88-97F0-2BB34A4DCCFDQ37748557-A894FA8D-27F4-4F1D-A545-01E1660B915FQ41926328-86A9FA15-8E45-4794-BA87-8A079CA089C0Q42474064-4FF961F3-D66C-4C5B-A96A-B5BABE0B0606Q45352889-9406B320-0D53-4B70-AA84-E055FA1932C8Q47556623-65687F1D-03B9-4722-A9B7-336B60AFBAA9Q51401529-F39D8F36-2213-4AC3-A942-826B68D4599BQ58123468-DFE63846-AE85-4F16-849A-EAB49184989FQ59050935-6AACC195-1EC4-4202-AC67-B5CD3C8734BB
P2860
Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Immune suppression as the etio ...... c hepatitis B virus infection.
@ast
Immune suppression as the etio ...... c hepatitis B virus infection.
@en
Immune suppression as the etio ...... c hepatitis B virus infection.
@nl
type
label
Immune suppression as the etio ...... c hepatitis B virus infection.
@ast
Immune suppression as the etio ...... c hepatitis B virus infection.
@en
Immune suppression as the etio ...... c hepatitis B virus infection.
@nl
prefLabel
Immune suppression as the etio ...... c hepatitis B virus infection.
@ast
Immune suppression as the etio ...... c hepatitis B virus infection.
@en
Immune suppression as the etio ...... c hepatitis B virus infection.
@nl
P2093
P2860
P356
P1476
Immune suppression as the etio ...... c hepatitis B virus infection.
@en
P2093
Avettand-Fenoel V
Thibault V
P2860
P304
P356
10.1128/JCM.00234-06
P407
P577
2006-06-01T00:00:00Z